Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M7,170Revenue $M1,875Net Margin (%)14.4Z-Score5.4
Enterprise Value $M7,470EPS $1.6Operating Margin %18.2F-Score6
P/E(ttm))19.2Cash Flow Per Share $2.4Pre-tax Margin (%)18.6Higher ROA y-yY
Price/Book5.410-y EBITDA Growth Rate %23.9Quick Ratio1.0Cash flow > EarningsN
Price/Sales3.45-y EBITDA Growth Rate %98.0Current Ratio1.5Lower Leverage y-yN
Price/Cash Flow14.3y-y EBITDA Growth Rate %40.7ROA % (ttm)11.8Higher Current Ratio y-yY
Dividend Yield %0.6Insider Buy (3m)0ROE % (ttm)23.0Less Shares Outstanding y-yN
Payout Ratio %12.0Shares Outstanding M170ROI % (ttm)2.9Gross Margin Increase y-yY

Gurus Latest Trades with RDY

Number of guru portfolios checked: 54.

No Entry found!

RDY is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


RDY: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about RDY :

    Quarterly/Annual Reports about RDY:

      News about RDY:

      Articles On GuruFocus.com
      Should You Buy Actavis? Mar 18 2014 
      Dr. Reddy’s Laboratories: Should Continue to Gain Market Share in Lucrative Markets May 25 2012 
      5 Mid-Cap Healthcare Dividend Stocks with Perfect Earnings Growth Dec 05 2011 
      Abbott Laboratories and the “India Cure” for the Ailing Pharmaceutical Industry May 26 2010 
      Dr. Reddy’s Q3 FY09 Revenue at Rs. 18,401 million, EBITDA at Rs. 3,453 million, PAT at Rs. 1,924 m Jan 20 2009 

      More From Our Partners
      Mylan Inks Two Separate Agreements - Analyst Blog Apr 16 2014 - ZACKS

      Add Notes, Comments or Ask Questions

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK
      Hide